Cathepsin E regulates the presentation of tetanus toxin C-fragment in PMA activated primary human B cells

Biochemical and Biophysical Research Communications

Volumn 377, Issue 4, 2008, Pages 1299-1303

  Burster, Timo ^a   Reich, Michael ^a   Zaidi, Nousheen ^b   Voelter, Wolfgang ^b   Boehm, Bernhard O ^a   Kalbacher, Hubert ^b  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Antigen presentation processing; Cathepsin E; MHC

Indexed keywords

ASPARTIC PROTEINASE; CATHEPSIN E; PEPSTATIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEINASE INHIBITOR; TETANUS TOXIN;

ARTICLE; BONE MARROW CELL; CELL MEMBRANE PERMEABILITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ANTIGEN PRESENTATION; B-LYMPHOCYTES; CATHEPSIN E; DENDRITIC CELLS; HUMANS; LYMPHOCYTE ACTIVATION; PEPSTATINS; PEPTIDE FRAGMENTS; TETANUS TOXIN; TETRADECANOYLPHORBOL ACETATE;

MURINAE;

EID: 56349147815     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.10.162     Document Type: Article

References (19)

1. Chapman H.A. Endosomal proteases in antigen presentation. Curr. Opin. Immunol. 18 (2006) 78-84
2. Busch R., Rinderknecht C.H., Roh S., Lee A.W., Harding J.J., Burster T., Hornell T.M., and Mellins E.D. Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression. Immunol. Rev. 207 (2005) 242-260
3. Zavasnik-Bergant T., and Turk B. Cysteine cathepsins in the immune response. Tissue Antigens 67 (2006) 349-355
4. Watts C., Matthews S.P., Mazzeo D., Manoury B., and Moss C.X. Asparaginyl endopeptidase: case history of a class II MHC compartment protease. Immunol. Rev. 207 (2005) 218-228
5. Rudensky A., and Beers C. Lysosomal cysteine proteases and antigen presentation. Ernst Schering Res. Found. Workshop (2006) 81-95
6. Villadangos J.A., Schnorrer P., and Wilson N.S. Control of MHC class II antigen presentation in dendritic cells: a balance between creative and destructive forces. Immunol. Rev. 207 (2005) 191-205
7. Chain B.M., Free P., Medd P., Swetman C., Tabor A.B., and Terrazzini N. The expression and function of cathepsin E in dendritic cells. J. Immunol. 174 (2005) 1791-1800
8. Solcia E., Paulli M., Silini E., Fiocca R., Finzi G., Kindl S., Boveri E., Bosi F., Cornaggia M., Capella C., et al. Cathepsin E in antigen-presenting Langerhans and interdigitating reticulum cells. Its possible role in antigen processing. Eur. J. Histochem. 37 (1993) 19-26
9. Sealy L., Mota F., Rayment N., Tatnell P., Kay J., and Chain B. Regulation of cathepsin E expression during human B cell differentiation in vitro. Eur. J. Immunol. 26 (1996) 1838-1843
10. Sakai H., Saku T., Kato Y., and Yamamoto K. Quantitation and immunohistochemical localization of cathepsins E and D in rat tissues and blood cells. Biochim. Biophys. Acta 991 (1989) 367-375
11. Nishioku T., Hashimoto K., Yamashita K., Liou S.Y., Kagamiishi Y., Maegawa H., Katsube N., Peters C., von Figura K., Saftig P., Katunuma N., Yamamoto K., and Nakanishi H. Involvement of cathepsin E in exogenous antigen processing in primary cultured murine microglia. J. Biol. Chem. 277 (2002) 4816-4822
12. Bennett K., Levine T., Ellis J.S., Peanasky R.J., Samloff I.M., Kay J., and Chain B.M. Antigen processing for presentation by class II major histocompatibility complex requires cleavage by cathepsin E. Eur. J. Immunol. 22 (1992) 1519-1524
13. Zaidi N., Burster T., Sommandas V., Herrmann T., Boehm B.O., Driessen C., Voelter W., and Kalbacher H. A novel cell penetrating aspartic protease inhibitor blocks processing and presentation of tetanus toxoid more efficiently than pepstatin A. Biochem. Biophys. Res. Commun. 364 (2007) 243-249
14. Kessler T., Reich M., Jahn G., Tolosa E., Beck A., Kalbacher H., Overkleeft H., Schempp S., and Driessen C. Human cytomegalovirus infection interferes with major histocompatibility complex type II maturation and endocytic proteases in dendritic cells at multiple levels. J. Gen. Virol. 89 (2008) 2427-2436
15. Greenbaum D., Medzihradszky K.F., Burlingame A., and Bogyo M. Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools. Chem. Biol. 7 (2000) 569-581
16. Zaidi N., Herrmann T., Baechle D., Schleicher S., Gogel J., Driessen C., Voelter W., and Kalbacher H. A new approach for distinguishing cathepsin E and D activity in antigen-processing organelles. FEBS J. 274 (2007) 3138-3149
17. Endl J., Rosinger S., Schwarz B., Friedrich S.O., Rothe G., Karges W., Schlosser M., Eiermann T., Schendel D.J., and Boehm B.O. Coexpression of CD25 and OX40 (CD134) receptors delineates autoreactive T-cells in type 1 diabetes. Diabetes 55 (2006) 50-60
18. Burster T., Beck A., Tolosa E., Schnorrer P., Weissert R., Reich M., Kraus M., Kalbacher H., Haring H.U., Weber E., Overkleeft H., and Driessen C. Differential processing of autoantigens in lysosomes from human monocyte-derived and peripheral blood dendritic cells. J. Immunol. 175 (2005) 5940-5949
19. Tesmer L.A., Lundy S.K., Sarkar S., and Fox D.A. Th17 cells in human disease. Immunol. Rev. 223 (2008) 87-113